opentargets-database

To identify therapeutic targets for a specific disease, you query target-disease associations and retrieve supporting genetic evidence. This approach integrates human genetics, omics, and literature data to systematically prioritize potential drug targets.

Finding drug repurposing opportunities involves querying curated biological and clinical information for new indications. You can discover existing drugs and assess their potential against new therapeutic targets through integrated chemical and pharmacological data.

Yes, you can retrieve druggability and safety profiles for target validation via a GraphQL API. Programmatic access allows you to assess a gene's tractability and known safety constraints by querying curated biomedical data directly.

Querying the Open Targets Platform API requires the requests dependency. You need this Python library to handle the GraphQL API requests and retrieve the comprehensive biomedical data for your drug discovery research.

For target-disease links in drug discovery, you can gather detailed genetic, omics, literature, and clinical evidence. This systematic evidence gathering supports competitive intelligence and helps validate therapeutic target prioritization.